OBJECTIVES: To compare a commercially available, level III in-home diagnostic sleep test (Embletta, Embletta USA) and in-laboratory polysomnography (PSG) in women with suspected obstructive sleep apnea (OSA). METHODS: Consecutive women scheduled for routine PSG testing for evaluation of clinically suspected OSA and who met inclusion⁄exclusion criteria, were invited to participate. An in-home Embletta portable monitor test was performed one week before or after diagnostic PSG. RESULTS: Forty-seven of 96 women who met the inclusion⁄exclusion criteria agreed to participate. The mean (± SD) age of the patients was 52.0 ± 11.0 years, with a mean body mass index of 34.86 ± 9.04 kg⁄m2, and 66% (31 of 47) of patients were at high risk for OSA according to the Berlin score. Paired analysis of the overall population revealed no significant difference in mean apnea⁄hypopnea index (AHI) between the two diagnostic methods (P = 0.475). At an AHI of ≥ 5, the Embletta test was highly sensitive (90.6%) in determining abnormal versus normal OSA, with a positive predictive value of 82.7%. However, a higher Embletta AHI threshold of ≥ 10 may be more useful, with a higher level of agreement (kappa coefficient) with PSG testing and a positive predictive value of 92.3%. The in-home study was less useful at distinguishing severe from nonsevere OSA, yielding a sensitivity of 50%. CONCLUSIONS: In women believed to be at high-risk for OSA, Embletta in-home sleep testing is useful for the detection of sleep disordered breathing.
OBJECTIVES: To compare a commercially available, level III in-home diagnostic sleep test (Embletta, Embletta USA) and in-laboratory polysomnography (PSG) in women with suspected obstructive sleep apnea (OSA). METHODS: Consecutive women scheduled for routine PSG testing for evaluation of clinically suspected OSA and who met inclusion⁄exclusion criteria, were invited to participate. An in-home Embletta portable monitor test was performed one week before or after diagnostic PSG. RESULTS: Forty-seven of 96 women who met the inclusion⁄exclusion criteria agreed to participate. The mean (± SD) age of the patients was 52.0 ± 11.0 years, with a mean body mass index of 34.86 ± 9.04 kg⁄m2, and 66% (31 of 47) of patients were at high risk for OSA according to the Berlin score. Paired analysis of the overall population revealed no significant difference in mean apnea⁄hypopnea index (AHI) between the two diagnostic methods (P = 0.475). At an AHI of ≥ 5, the Embletta test was highly sensitive (90.6%) in determining abnormal versus normal OSA, with a positive predictive value of 82.7%. However, a higher Embletta AHI threshold of ≥ 10 may be more useful, with a higher level of agreement (kappa coefficient) with PSG testing and a positive predictive value of 92.3%. The in-home study was less useful at distinguishing severe from nonsevere OSA, yielding a sensitivity of 50%. CONCLUSIONS: In women believed to be at high-risk for OSA, Embletta in-home sleep testing is useful for the detection of sleep disordered breathing.
Authors: Adam Blackman; Catherine McGregor; Robert Dales; Helen S Driver; Ilya Dumov; Jon Fleming; Kristin Fraser; Charlie George; Atul Khullar; Joe Mink; Murray Moffat; Glendon E Sullivan; John A Fleetham; Najib Ayas; T Douglas Bradley; Michael Fitzpatrick; John Kimoff; Debra Morrison; Frank Ryan; Robert Skomro; Frederic Series; Willis Tsai Journal: Can Respir J Date: 2010 Sep-Oct Impact factor: 2.409
Authors: Susanna S S Ng; Tat-On Chan; Kin-Wang To; Jenny Ngai; Alvin Tung; Fanny W S Ko; David S C Hui Journal: Respirology Date: 2010-02 Impact factor: 6.424
Authors: A T Mulgrew; G Nasvadi; A Butt; R Cheema; N Fox; J A Fleetham; C F Ryan; P Cooper; N T Ayas Journal: Thorax Date: 2008-01-30 Impact factor: 9.139
Authors: Dietlind L Wahner-Roedler; Eric J Olson; Sujata Narayanan; Richa Sood; Andrew C Hanson; Laura L Loehrer; Amit Sood Journal: Gend Med Date: 2007-12
Authors: Jennifer N Miller; Paula Schulz; Bunny Pozehl; Douglas Fiedler; Alissa Fial; Ann M Berger Journal: Sleep Breath Date: 2017-11-14 Impact factor: 2.816
Authors: John A Gjevre; Punam Pahwa; Chandima Karunanayake; Louise Hagel; Donna Rennie; Joshua Lawson; Roland Dyck; James Dosman Journal: Can Respir J Date: 2014-05-02 Impact factor: 2.409
Authors: John A Gjevre; Regina M Taylor-Gjevre; John K Reid; Robert Skomro; David Cotton Journal: J Clin Sleep Med Date: 2013-07-15 Impact factor: 4.062
Authors: Vishesh K Kapur; Dennis H Auckley; Susmita Chowdhuri; David C Kuhlmann; Reena Mehra; Kannan Ramar; Christopher G Harrod Journal: J Clin Sleep Med Date: 2017-03-15 Impact factor: 4.062